PRICE T ROWE ASSOCIATES INC /MD/ - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 90 filers reported holding HUMACYTE INC in Q4 2023. The put-call ratio across all filers is 1.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of HUMACYTE INC
ValueSharesWeighting
Q2 2024$135
+170.0%
28,069
+77.1%
0.00%
Q1 2024$50
+13.6%
15,853
+2.6%
0.00%
Q4 2023$44
+7.3%
15,448
+10.8%
0.00%
Q3 2023$41
+17.1%
13,936
+16.1%
0.00%
Q2 2023$35
-7.9%
12,0040.0%0.00%
Q1 2023$3812,0040.00%
Other shareholders
HUMACYTE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Endowment Wealth Management, Inc. 100,518$482,4860.35%
Monashee Investment Management LLC 280,000$1,344,0000.17%
United Asset Strategies, Inc. 218,308$1,047,8780.10%
HAMILTON LANE ADVISORS LLC 21,893$105,0860.08%
GSA CAPITAL PARTNERS LLP 224,179$1,0760.08%
David J Yvars Group 22,750$109,2000.07%
ARS Investment Partners, LLC 116,419$558,8110.05%
EntryPoint Capital, LLC 5,180$24,8640.04%
Virtu Financial LLC 103,163$4950.04%
Anson Funds Management LP 50,000$240,0000.03%
View complete list of HUMACYTE INC shareholders